109 related articles for article (PubMed ID: 16170033)
1. Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
Fujino H; Kondo K; Ishikura H; Maki H; Kinoshita H; Miyoshi T; Takahashi Y; Sawada N; Takizawa H; Nagao T; Sakiyama S; Monden Y
Mol Cancer Ther; 2005 Sep; 4(9):1409-16. PubMed ID: 16170033
[TBL] [Abstract][Full Text] [Related]
2. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor.
Maekawa R; Maki H; Wada T; Yoshida H; Nishida-Nishimoto K; Okamoto H; Matsumoto Y; Tsuzuki H; Yoshioka T
Clin Exp Metastasis; 2000; 18(1):61-6. PubMed ID: 11206840
[TBL] [Abstract][Full Text] [Related]
3. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
[TBL] [Abstract][Full Text] [Related]
4. Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
Katori H; Baba Y; Imagawa Y; Nishimura G; Kagesato Y; Takagi E; Ishii A; Yanoma S; Maekawa R; Yoshioka T; Nagashima Y; Kato Y; Tsukuda M
Cancer Lett; 2002 Apr; 178(2):151-9. PubMed ID: 11867199
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Ohta M; Konno H; Tanaka T; Baba M; Kamiya K; Oba K; Kaneko T; Syouji T; Igarashi A; Nakamura S
Jpn J Cancer Res; 2001 Jun; 92(6):688-95. PubMed ID: 11429059
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation.
Kozaki K; Miyaishi O; Tsukamoto T; Tatematsu Y; Hida T; Takahashi T; Takahashi T
Cancer Res; 2000 May; 60(9):2535-40. PubMed ID: 10811136
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
Matsushita A; Onda M; Uchida E; Maekawa R; Yoshioka T
Int J Cancer; 2001 May; 92(3):434-40. PubMed ID: 11291083
[TBL] [Abstract][Full Text] [Related]
8. Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells.
Nakabayashi H; Yawata T; Shimizu K
BMC Cancer; 2010 Jun; 10():339. PubMed ID: 20587068
[TBL] [Abstract][Full Text] [Related]
9. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
[TBL] [Abstract][Full Text] [Related]
10. Suppression of mediastinal metastasis by uracil-tegafur or cis-diamminedichloroplatinum(II) using a lymphogenous metastatic model in a human lung cancer cell line.
Ishikura H; Kondo K; Miyoshi T; Kinoshita H; Takahashi Y; Fujino H; Monden Y
Clin Cancer Res; 2001 Dec; 7(12):4202-8. PubMed ID: 11751521
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
[TBL] [Abstract][Full Text] [Related]
12. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
Oba K; Konno H; Tanaka T; Baba M; Kamiya K; Ohta M; Kaneko T; Shouji T; Igarashi A; Nakamura S
Cancer Lett; 2002 Jan; 175(1):45-51. PubMed ID: 11734335
[TBL] [Abstract][Full Text] [Related]
13. MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
Gao CC; Gong BG; Wu JB; Cheng PG; Xu HY; Song DK; Li F
Med Oncol; 2015 Jan; 32(1):418. PubMed ID: 25471789
[TBL] [Abstract][Full Text] [Related]
14. Artificial lymphogenous metastatic model using orthotopic implantation of human lung cancer.
Ishikura H; Kondo K; Miyoshi T; Kinoshita H; Hirose T; Monden Y
Ann Thorac Surg; 2000 Jun; 69(6):1691-5. PubMed ID: 10892908
[TBL] [Abstract][Full Text] [Related]
15. Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
Fujino H; Kondo K; Miyoshi T; Ishikura H; Takahashi Y; Sawada N; Hirose Y; Takizawa H; Nagao T; Sakiyama S; Monden Y
Oncol Rep; 2003; 10(6):1709-15. PubMed ID: 14534683
[TBL] [Abstract][Full Text] [Related]
16. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
[TBL] [Abstract][Full Text] [Related]
17. Model for mediastinal lymph node metastasis produced by orthotopic intrapulmonary implantation of lung cancer cells in mice.
Yamaura T; Doki Y; Murakami K; Saiki I
Hum Cell; 1999 Dec; 12(4):197-204. PubMed ID: 10834106
[TBL] [Abstract][Full Text] [Related]
18. SCID mouse lymphogenous metastatic model of human lung cancer constructed using orthotopic inoculation of cancer cells.
Miyoshi T; Kondo K; Ishikura H; Kinoshita H; Matsumori Y; Monden Y
Anticancer Res; 2000; 20(1A):161-3. PubMed ID: 10769649
[TBL] [Abstract][Full Text] [Related]
19. Organ heterogeneity of host-derived matrix metalloproteinase expression and its involvement in multiple-organ metastasis by lung cancer cell lines.
Shiraga M; Yano S; Yamamoto A; Ogawa H; Goto H; Miki T; Miki K; Zhang H; Sone S
Cancer Res; 2002 Oct; 62(20):5967-73. PubMed ID: 12384564
[TBL] [Abstract][Full Text] [Related]
20. Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer.
Yamaura T; Murakami K; Doki Y; Sugiyama S; Misaki T; Yamada Y; Saiki I
Neoplasia; 2000; 2(4):315-24. PubMed ID: 11005566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
